We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
With less than two months to go before election day, drug prices are increasingly being used in politics, with both the Democratic party and AARP releasing new reports.
Flaws in the Centers for Medicare & Medicaid Services’ (CMS) reimbursement policy for Amgen’s anemia drug Epogen may foretell problems with the Part D drug plan, researchers say.
Dey, a subsidiary of Germany’s Merck KGaA, will be going up against the Department of Justice (DOJ) in court after the federal agency jumped into a whistleblower suit alleging Medicare and Medicaid fraud.
The Centers for Medicare & Medicaid Services (CMS) reimbursement policy for Amgen’s anemia drug Epogen is based on flawed and incomplete data, contradicting the FDA and foretelling potential problems with the Part D drug plan, researchers say.
Medicare payments for inhalation drugs will be assessed differently to ensure pharmacies are making compounded products strictly for medical needs and not to turn a large profit, according to the official in charge of Medicare.
Medicare payments for inhalation drugs will be assessed differently to ensure pharmacies are making compounded products strictly for medical needs and not to turn a large profit, according to the official in charge of Medicare.
HHS is arguing that drug and devicemakers cannot be trusted to abide by the law and therefore cannot receive a new protection from the anti-kickback statute designed to promote adoption of electronic health records.
The HHS Secretary’s Advisory Committee on Human Research Protections (SACHRP) will seek legislation developing uniform human research protections in place of the current patchwork system, the group decided at an Aug. 1 meeting in Bethesda, Md.
Centers for Medicare & Medicaid Services (CMS) Administrator Mark McClellan July 20 addressed the opposition his agency has seen to its proposals to change the Medicare inpatient prospective payment system in 2007.
Some doctors are buying fewer medical devices because of planned cuts to Medicare reimbursements for certain medical imaging services. The cuts are slated to start in January 2007.